Micron (MU) stock tumbled 20% after Google’s TurboQuant reveal, but analysts see buying opportunity with price targets suggesting 51% upside potential.
Browsing: Stocks
Micron (MU) stock plunged 20% after Google’s TurboQuant reveal. Morgan Stanley and Wall Street analysts explain why the selloff creates a buying opportunity.
Evercore names Microsoft (MSFT), Amazon (AMZN), and Caterpillar (CAT) as leading picks for market stabilization. Futures climb amid shifting geopolitical tone.
Nakamoto (NAKA) shares fell 7.16% after selling 284 BTC at a 40% loss. The company reported a $52M net loss for 2025 and plans to exit healthcare operations.
American Bitcoin (ABTC) reaches 7,000 BTC worth $474M, but shares fall 88% to $0.84. Treasury grows while stock enters penny territory.
Mitsubishi Corporation joins JPMorgan’s Kinexys blockchain network, which has processed over $3T in transactions and targets $10B in daily volume.
Bitcoin holds $67,500 as Trump signals potential end to Iran conflict. Crypto outperforms stocks amid S&P 500’s longest decline since 2022.
Square auto-activates Bitcoin payments for millions of U.S. merchants with instant dollar conversion, no fees through 2026, and zero volatility risk.
Bank of America identifies NVIDIA (NVDA), Broadcom (AVGO), and AMD as leading AI chip stocks with strong price targets amid surging AI demand.
Nvidia (NVDA) stock gained as Mistral AI ordered ~$575M in GB300 GPUs and space startup Starcloud secured $170M for orbital data centers.
Nvidia (NVDA) stock gains as Mistral AI orders massive GPU fleet and Starcloud advances space-based AI computing with $170M funding round.
Carvana (CVNA) stock dropped 6% after announcing a forward split, as investors worry about governance disputes, oil prices, and weakening consumer sentiment.
ARK Invest sold $27M in Nvidia, Meta, Tesla, and AMD on March 27 while buying Arcturus Therapeutics, continuing Cathie Wood’s week-long tech exit.
Netflix (NFLX) receives mixed analyst ratings after implementing a 10% U.S. price hike. Wall Street consensus shows 22% upside potential ahead.
Boston Scientific (BSX) dropped 8% to 52-week lows as Raymond James cut its price target to $88 on concerns about slowing EP and Watchman device growth.